ARDELYX, INC. Inventory, Work in Process, Gross
ARDELYX, INC. (ARDX) had Inventory, Work in Process, Gross of $87.04 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryWorkInProcess · last filed 2026-08-06
- 2026-06-30: Inventory, Work in Process, Gross $87.04M.
- 2026-03-31: Inventory, Work in Process, Gross $90.04M.
- 2025-12-31: Inventory, Work in Process, Gross $88.26M.
- 2025-09-30: Inventory, Work in Process, Gross $92.96M.
| Period end | Inventory, Work in Process, Gross |
|---|---|
| 2026-06-30 | $87.04M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $90.04M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $88.26M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $92.96M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $88.50M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $60.99M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $58.69M 10-K · filed 2026-02-19 |
| 2024-09-30 | $57.34M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $55.14M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $54.21M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $24.58M 10-K · filed 2025-02-20 |
| 2023-09-30 | $22.96M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $23.53M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $22.57M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $5.32M 10-K · filed 2024-02-22 |
| 2022-09-30 | $2.91M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $3.61M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $2.51M 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |